(S)-2-{3-[(S)-1-Carboxy-3-(1H-tetrazol-5-yl)-propyl]-ureido}-4-(1H-tetrazol-5-yl)-butyric acid

ID: ALA49271

Chembl Id: CHEMBL49271

PubChem CID: 11152839

Max Phase: Preclinical

Molecular Formula: C11H16N10O5

Molecular Weight: 368.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H](CCc1nnn[nH]1)C(=O)O)N[C@@H](CCc1nnn[nH]1)C(=O)O

Standard InChI:  InChI=1S/C11H16N10O5/c22-9(23)5(1-3-7-14-18-19-15-7)12-11(26)13-6(10(24)25)2-4-8-16-20-21-17-8/h5-6H,1-4H2,(H,22,23)(H,24,25)(H2,12,13,26)(H,14,15,18,19)(H,16,17,20,21)/t5-,6-/m0/s1

Standard InChI Key:  CJGKWYDINDMVEE-WDSKDSINSA-N

Associated Targets(Human)

NAALAD2 Tchem NAALADase II (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.31Molecular Weight (Monoisotopic): 368.1305AlogP: -2.52#Rotatable Bonds: 10
Polar Surface Area: 224.65Molecular Species: ACIDHBA: 9HBD: 6
#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.75CX Basic pKa: CX LogP: -2.38CX LogD: -12.48
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.26Np Likeness Score: -0.79

References

1. Kozikowski AP, Zhang J, Nan F, Petukhov PA, Grajkowska E, Wroblewski JT, Yamamoto T, Bzdega T, Wroblewska B, Neale JH..  (2004)  Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.,  47  (7): [PMID:15027864] [10.1021/jm0306226]

Source